Anaphylaxis: NICE Quality Standard Guidance
NICE (National Institute for Health and Care Excellence) has published Quality Standard QS119, focusing on the identification, management, and prevention...
Filter:
NICE Recommends Digital Technology to Help Diagnose ADHD in Children and Young People
The National Institute for Health and Care Excellence (NICE) has endorsed the use of digital technology, specifically the QbTest, to...
Guidance on Intensive and Assertive Community Mental Health Treatment
The NHS England has published new guidance to support integrated care boards (ICBs) in enhancing community mental health services. This...
MHRA Approves Vibegron for Overactive Bladder Syndrome
The Medicines and Healthcare products Regulatory Agency (MHRA) has approved vibegron (Obgemsa) for treating adults with overactive bladder (OAB) syndrome....
Our Environment, Our Health
The Lancet's recent editorial, "Our Environment, Our Health," published in the July 2024 issue, explores the critical links between public...
Children and Young People Diabetes Toolkit
The NHS England Children and Young People Diabetes Toolkit is designed to support integrated care systems (ICSs) in delivering high-quality...
Tegretol (Carbamazepine): Comprehensive Overview
Tegretol (Carbamazepine) is an anticonvulsant and mood-stabilising drug primarily used to treat epilepsy, neuropathic pain, and bipolar disorder. This article...
The Complete Routine Immunisation Schedule
The UK government has published the updated routine immunisation schedule, outlining the recommended vaccines for individuals from infancy through adulthood....
Management of Temporomandibular Disorders (TMDs)
Temporomandibular disorders (TMDs) are a group of conditions affecting the temporomandibular joint (TMJ), muscles of mastication, and associated structures. The...
Topiramate (Topamax): New Safety Measures Including a Pregnancy Prevention Programme
The UK government has introduced new safety measures for topiramate (Topamax), a medication used to treat epilepsy and migraines. These...
Medicine Supply Notification: Disopyramide (Rythmodan) Retard 250mg Modified-Release Tablets and Disopyramide (Rythmodan) 100mg Capsules
The Centre for Pharmacy Postgraduate Education (CPPE) has issued a supply notification for Disopyramide (Rythmodan) Retard 250mg modified-release tablets and...
The Lancet Article on Health Inequalities in Europe: An Overview
The Lancet has published a comprehensive study addressing health inequalities across Europe. This article highlights the disparities in health outcomes...